申请人:ONO PHARMACEUTICAL CO., LTD.
公开号:EP0405784A1
公开(公告)日:1991-01-02
Benzisoquinoline derivatives of the formula:
wherein R¹ is hydrogen, C1-4 alkyl, C1-4 alkoxy, hydroxy or halogen;
R³ is hydrogen or C1-4 alkyl;
R⁴ is hydrogen or C1-6 alkyl;
l is 1-6;
m is 1 or 2:
n is 1-3
and non-toxic acid addition salts or hydrates thereof possess antagonistic activity against 5-HT₃ receptor, and therefore are useful for the prevention and/or treatment of diseases which are induced when 5-HT acts on 5-HT₃ receptors (especially vomiting induced by the administration of anti-cancer agents).
式中的苯并异喹啉衍生物:
其中 R¹ 是氢、C1-4 烷基、C1-4 烷氧基、羟基或卤素;
R³ 是氢或 C1-4 烷基
R⁴ 是氢或 C1-6 烷基;
l 是 1-6;
m 是 1 或 2:
n 是 1-3
及其无毒酸加成盐或水合物具有拮抗 5-HT₃ 受体的活性,因此可用于预防和/或治疗 5-HT 作用于 5-HT₃ 受体时诱发的疾病(尤其是服用抗癌药物诱发的呕吐)。